MedPath
NMPA Approval

Doxazosin Mesylate Tablets

国药准字H20031308

January 9, 2020

Drug Information

甲磺酸多沙唑嗪片

仲维

仲维

片剂

按多沙唑嗪计1mg

化学药品

January 9, 2020

Company Information

Applicant Company

Manufacturing Company

驻马店市驿城区光明路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸多沙唑嗪片 - NMPA 批准文号 | MedPath